SCHEMBL20159394

SCHEMBL20159394

CC1(C)CC(c2ccc(Br)cc2)=NNC1=O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.50
KCNH2 Q12809 2/20 0.50
PDE4B Q07343 4/20 0.42
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
POLB P06746 1/20 0.42
PDE3B Q13370 4/20 0.39
PDE3A Q14432 4/20 0.39
PDE4A P27815 3/20 0.39
PDE4C Q08493 3/20 0.39
PDE4D Q08499 3/20 0.39
AXL P30530 1/20 0.38
GAA P10253 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 1/20 0.35
NPY1R P25929 1/20 0.35
NPY2R P49146 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20138742 0.84 HRH3 (0.53) HRH3KCNH2PDE4BSMN1; SMN2PDE3B
SCHEMBL11568277 0.84 HRH3 (0.50) HRH3KCNH2PDE4BMAPTSMN1; SMN2
SCHEMBL10518939 0.77 PDE3B (0.48) HRH3KCNH2MAPTSMN1; SMN2POLB
SCHEMBL10519140 0.74 PDE3B (0.64) HRH3KCNH2PDE4BPDE3BPDE3A
SCHEMBL6405046 0.73 PDE3B (0.44) HRH3KCNH2PDE4BPDE3BPDE3A
SCHEMBL8714845 0.72 HRH3 (0.44) HRH3KCNH2PDE4BPDE3BPDE3A
SCHEMBL20529210 0.72 PDE4B (0.55) HRH3KCNH2PDE4BPDE3BPDE3A
SCHEMBL21821442 0.72 PDE4B (0.55) HRH3KCNH2PDE4BPDE3BPDE3A
SCHEMBL927560 0.70 SMN1; SMN2 (0.70) HRH3KCNH2PDE4BMAPTSMN1; SMN2
SCHEMBL20142960 0.70 SMN1; SMN2 (0.41) PDE4BMAPTSMN1; SMN2PDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021013693-A1 ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2021-01-28 WO disclosed
WO-2018086703-A1 DIHYDROPYRIDAZINONES SUBSTITUTED WITH PHENYLUREAS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 WO disclosed